If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Contracts round-up: GETECH, Norcon, Avacta

Mon, 24th Sep 2012 09:41
GETECH, the oil services business specialising in the provision of exploration data and geological exploration studies, has announced a new call-off contract, valued at one million euro, with a major existing client. The order includes a committment to GETECH's Global Programmes, as well as purchase of its Trident gravity dataset. The client is the seventh to sign up to the core elements of GETECH's CryoSat research project, which is a pilot study aimed at improving the exploration value of satellite gravity data. Avacta Group, which provides analytical and diagnostic technologies and services to the pharmaceutical and animal healthcare sectors, has signed its third agreement with Pall Corp, which will sell and distribute Avacta's protein drug development tool, known as Optim, in India. Norcon, the global communications network specialist, has confirmed that the large new project secured in Indonesia, announced last week, is with Indosat. The project is to enhance, expand and improve the quality of Indosat's cellular network. "Diversification of our revenue base into new geographies is the key strategic priority for Norcon and this deal with Indosat is evidence that we are making progress here," the firm's acting CEO said. NR Avacta Group Getech Grp

Shares in this article

Related News

EARNINGS AND TRADING: Clontarf loss narrows, eyes new opportunities
25 Jun 2026

EARNINGS AND TRADING: Clontarf loss narrows, eyes new opportunities

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...

Avacta agrees design of pivotal US cancer therapy trial
25 Jun 2026

Avacta agrees design of pivotal US cancer therapy trial

(Sharecast News) - Avacta said on Thursday it had agreed the design of a pivotal US trial for its lead cancer therapy with the US Food and Drug Admini...

Avacta hails "strong progress" in first half of 2026
22 Jun 2026

Avacta hails "strong progress" in first half of 2026

(Alliance News) - Avacta Group PLC on Monday said it continued its "strong progress" in the first half of 2026.